R Weitzman, N Sauter, EF Eriksen, PG Tarassoff… - Critical reviews in …, 2007 - Elsevier
In light of recent reports of osteonecrosis of the jaw (ONJ) in cancer patients whose treatment regimens include an intravenous bisphosphonate, Novartis convened an …
MH Abu-Id, PH Warnke, J Gottschalk, I Springer… - Journal of Cranio …, 2008 - Elsevier
INTRODUCTION: Bisphosphonates (BPs) have transformed our ability to treat certain malignancies, osteoporosis and hypercalcaemia. This class of drug is assumed to be well …
N Yarom, R Yahalom, Y Shoshani, W Hamed… - Osteoporosis …, 2007 - Springer
Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of bisphosphonate therapy for cancer. Several ONJ cases of patients using oral bisphosphonates have been …
BACKGROUND: Bisphosphonates are medications that impact bone reformation by inhibiting osteoclast function. Osteonecrosis of the jaw has been reported among patients …
JM Fullmer, WC Scarfe, GM Kushner, B Alpert… - British Journal of Oral …, 2007 - Elsevier
AIMS: To report the imaging features of osteomyelitis of the mandible in various two- dimensional multiplanar and three-dimensional reformations using cone beam computed …
E Nastro, C Musolino, A Allegra, G Oteri, M Cicciù… - Acta …, 2007 - karger.com
Osteonecrosis of the jaw is an unremitting adverse outcome associated with bisphosphonate therapy in patients with multiple myeloma or bone metastases from solid …
C Barragan-Adjemian, L Lausten, DB Ang… - Cells Tissues …, 2008 - karger.com
Intravenous bisphosphonate (BP) therapy has become the standard of care for the treatment of cancers that metastasize to bone. BPs are associated with osteonecrosis of alveolar …
MH Abu-Id, Y Açil, J Gottschalk, T Kreusch - Mund-, Kiefer-und …, 2006 - Springer
Zusammenfassung Hintergrund Im Jahr 2003 wurde erstmals über den Zusammenhang zwischen Bisphosphonaten (BP) und Osteonekrosen der Kiefer (ONJ) berichtet. Seitdem …
MH Abu-Id, Y Acil, J Gottschalk… - Oral and Maxillofacial …, 2006 - researchgate.net
Zusammenfassung Hintergrund: Im Jahr 2003 wurde erstmals über den Zusammenhang zwischen Bisphosphonaten (BP) und Osteonekrosen der Kiefer (ONJ) berichtet. Seitdem …